Assessing hepatitis C burden and treatment effectiveness through the British Columbia hepatitis testers cohort (BC-HTC): Design and characteristics of linked and unlinked participants

PLoS ONE

Volumn 11, Issue 3, 2016, Pages

  Janjua, Naveed Zafar ^a,b   Kuo, Margot ^a   Chong, Mei ^a   Yu, Amanda ^a   Alvarez, Maria ^a   Cook, Darrel ^a   Armour, Rosemary ^c   Aiken, Ciaran ^a   Li, Karen ^c   Rizi, Seyed Ali Mussavi ^d   Woods, Ryan ^e   Godfrey, David ^c   Wong, Jason ^a,b   Gilbert, Mark ^a,b,f   Tyndall, Mark W ^a,b   Krajden, Mel ^a,b  

^a BRITISH COLUMBIA CENTRE FOR DISEASE CONTROL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c MINISTRY OF HEALTH   (Canada)

^d PROVINCIAL HEALTH SERVICES AUTHORITY   (Canada)

^e BRITISH COLUMBIA CANCER AGENCY   (Canada)

^f ONTARIO HIV TREATMENT NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; CANADA; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; CONTROLLED STUDY; COST OF ILLNESS; DISEASE SURVEILLANCE; FEMALE; HEALTH INSURANCE; HEPATITIS B; HEPATITIS C; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MIXED INFECTION; PATIENT ASSESSMENT; SEX DIFFERENCE; TUBERCULOSIS; VIRUS LOAD; BRITISH COLUMBIA; CLINICAL TRIAL; COMPARATIVE STUDY; EPIDEMIOLOGICAL MONITORING; FACTUAL DATABASE; FOLLOW UP; MULTICENTER STUDY; RETROSPECTIVE STUDY;

BRITISH COLUMBIA; COST OF ILLNESS; DATABASES, FACTUAL; EPIDEMIOLOGICAL MONITORING; FEMALE; FOLLOW-UP STUDIES; HEPATITIS C; HUMANS; MALE; RETROSPECTIVE STUDIES;

EID: 84962615918     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0150176     Document Type: Article

References (36)

1. Trubnikov M, Yan P, Archibald C. Estimated prevalence of Hepatitis C virus infection in Canada, 2011. CCDR. 2014; 40(19): 429-42.
2. Sulkowski MS, Gardiner DF, Rodriguez-Torres M, Reddy KR, Hassanein T, Jacobson I, et al. Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection. The New England journal of medicine. 2014; 370(3):211-21. Epub 2014/01/17. doi: 10.1056/NEJMoa1306218 PMID: 24428467.
3. Kowdley KV, Lawitz E, Poordad F, Cohen DE, Nelson DR, Zeuzem S, et al. Phase 2b trial of interferonfree therapy for hepatitis C virus genotype 1. The New England journal of medicine. 2014; 370(3):222-32. Epub 2014/01/17. doi: 10.1056/NEJMoa1306227 PMID: 24428468.
4. AbbVie Completes Largest Phase III Program of an All-Oral, Interferon-Free Therapy for the Treatment of Hepatitis C Genotype 1: AbbVie; 2014 [cited 2014 09/02/2014]. Available from: http://abbvie. mediaroom.com/2014-01-31-AbbVie-Completes-Largest-Phase-III-Program-of-an-All-Oral-Interferon-Free-Therapy-for-the-Treatment-of-Hepatitis-C-Genotype-1#researchAndInnovation.
5. Knox R. $1,000 Pill For Hepatitis C Spurs Debate Over Drug Prices. NPR. 2013.
6. Schinazi R, Halfon P, Marcellin P, Asselah T. HCV direct-acting antiviral agents: the best interferonfree combinations. Liver international: official journal of the International Association for the Study of the Liver. 2014; 34 Suppl 1:69-78. Epub 2014/01/01. doi: 10.1111/liv.12423 PMID: 24373081.
7. Management of Specific Diseases: Hepatitis C. 2013. In: Communicable Disease Control Manual [Internet]. Vancouver: BC Centre for Disease Control. Available from: http://www.bccdc.ca/NR/ rdonlyres/CEC67337-3E94-4FD3-B21C-63A71014619D/0/CPS-Hep-Guidelines-HCV-20130709. pdf.
8. HIV Laboratory Testing: a Resource for Health Professionals. 2010 June 30, 2010. BC Centre for Disease Control. Available from: http://www.bccdc.ca/NR/rdonlyres/2982E293-BD82-436D-B193-F929B5CEEBEC/0/HIVTestinginBCResourceDocumentforHealthProfessionalsJune2010.pdf.
9. Nosyk B, Colley G, Yip B, Chan K, Heath K, Lima VD, et al. Application and validation of case-finding algorithms for identifying individuals with human immunodeficiency virus from administrative data in British Columbia, Canada. PloS one. 2013; 8(1):e54416. Epub 2013/02/06. doi: 10.1371/journal.pone. 0054416 [doi] PONE-D-12-25544 [pii]. PMID: 23382898; PubMed Central PMCID: PMC3557280.
10. Management of Specific Diseases: Hepatitis B. 2009. In: Communicable Disease Control Manual [Internet]. Vancouver: BC Centre for Disease Control. Available from: http://www.bccdc.ca/NR/ rdonlyres/CEC67337-3E94-4FD3-B21C-63A71014619D/0/CPS-Hep-Guidelines-HCV-20130709. pdf.
11. TB Manual. 2012. In: Communicable Disease Control Manual [Internet]. Vancouver: BC Centre for Disease Control. Available from: http://www.bccdc.ca/NR/rdonlyres/CEC67337-3E94-4FD3-B21C-63A71014619D/0/CPS-Hep-Guidelines-HCV-20130709.pdf.
12. [creator] BCMoH. Medical Services Plan (MSP) Payment Information File. Victoria British Columbia Ministry of Health [publisher]; 2013.
13. [creator] BCMoH. Discharge Abstract Database (Hospital Separations). Victoria British Columbia Ministry of Health [publisher]; 2013.
14. [creator] BCMoH. PharmaNet. Victoria British Columbia Ministry of Health [publisher]; 2013.
15. [creator] BVSA. Vital Statistics Deaths. Victoria BC Vital Statistics Agency [publisher]; 2014.
16. [creator] BCA. BC Cancer Agency Registry Data BC Cancer Agency [publisher]; 2013.
17. Rizi SA, Roudsari A. Development of a public health reporting data warehouse: lessons learned. Studies in health technology and informatics. 2013; 192:861-5. Epub 2013/08/08. PMID: 23920680.
18. Kendall P. HIV now reportable. BCMJ,. 2003; 45(3):120.
19. Hottes TS, Gilbert M. Anonymous HIV Testing: Evidence Review and Environmental Scan. Vancouver: BC Centre for Disease Control, 2012.
20. Fortenberry JD, McFarlane M, Bleakley A. Relationships of stigma and shame to gonorrhea and HIV screening. American journal of public health. 2002; 92(3):378-81. PMID: 11867314
21. Hirano D, Gellert GA, Fleming K, Boyd D, Englender SJ, Hawks H. Anonymous HIV testing: the impact of availability on demand in Arizona. Am J Public Health. 1994; 84(12):2008-10. PMID: 7998649
22. Rossi I, Jeannin A, Dubois-Arber F, Guex P, Vannotti M. Comparison of the clientele of an anonymous HIV test centre and persons tested in the general population. AIDS Care. 1998; 10(1):89-103. PMID: 9536205
23. Bindman AB, Osmond D, Hecht FM, Lehman JS, Vranizan K, Keane D, et al. Multistate evaluation of anonymous HIV testing and access to medical care. Multistate Evaluation of Surveillance of HIV (MESH) Study Group. JAMA: the journal of the American Medical Association. 1998; 280(16):1416-20. PMID: 9801001.
24. Sasse A, Vincent A, Galand M, Ryckmans P, Liesnard C. High HIV prevalence among patients choosing anonymous and free testing in Belgium, 1990-2002. International journal of STD & AIDS. 2006; 17 (12):817-20. doi: 10.1258/095646206779307504 PMID: 17212858.
25. Adams MM, Berg CJ, McDermott JM, Gaudino JA, Casto DL, Wilson HG, et al. Evaluation of reproductive histories constructed by linking vital records. Paediatr Perinat Epidemiol. 1997; 11(1):78-92. PMID: 9018730.
26. Dougan S, Balogun MA, Elford J, Brant LJ, Sinka K, Evans BG, et al. Can current national surveillance systems in England and Wales monitor sexual transmission of hepatitis C among HIV-infected men who have sex with men? BMC public health. 2007; 7:7. doi: 10.1186/1471-2458-7-7 PMID: 17233919; PubMed Central PMCID: PMC1784083.
27. Palmateer NE, Hutchinson SJ, McLeod A, Codere G, Goldberg DJ. Comparison of deaths related to Hepatitis C and AIDS in Scotland. Journal of viral hepatitis. 2007; 14(12):870-4. doi: 10.1111/j.1365-2893.2007.00876.x PMID: 18070290.
28. McDonald SA, Hutchinson SJ, Innes HA, Allen S, Bramley P, Bhattacharyya D, et al. Attendance at specialist hepatitis clinics and initiation of antiviral treatment among persons chronically infected with hepatitis C: examining the early impact of Scotland's Hepatitis C Action Plan. Journal of viral hepatitis. 2014; 21(5):366-76. doi: 10.1111/jvh.12153 PMID: 24716639.
29. elSaadany S, Ricketts M, Giulivi A. Development of a computer linkage system for a blood recipient notification program in Nova Scotia. Canadian journal of public health = Revue canadienne de sante publique. 2002; 93(6):439-42. PMID: 12448867.
30. Nakhaee F, McDonald A, Black D, Law M. A feasible method for linkage studies avoiding clerical review: linkage of the national HIV/AIDS surveillance databases with the National Death Index in Australia. Australian and New Zealand Journal of Public Health. 2007; 31(4):308-12. doi: 10.1111/j.1753-6405.2007.00076.x PMID: 17725006
31. Kariminia A, Butler T, Corben S, Kaldor J, Levy M, Law M. Mortality among prisoners: how accurate is the Australian National Death Index? Aust N Z J Public Health. 2005; 29(6):572-5. PMID: 16366070.
32. Chamberlayne R, Green B, Barer ML, Hertzman C, Lawrence WJ, Sheps SB. Creating a populationbased linked health database: a new resource for health services research. Canadian journal of public health = Revue canadienne de sante publique. 1998; 89(4):270-3. Epub 1998/09/15. PMID: 9735524.
33. Bohensky MA, Jolley D, Sundararajan V, Pilcher DV, Evans S, Brand CA. Empirical aspects of linking intensive care registry data to hospital discharge data without the use of direct patient identifiers. Anaesthesia and intensive care. 2011; 39(2):202-8. Epub 2011/04/14. PMID: 21485667.
34. Korzeniewski SJ, Grigorescu V, Copeland G, Gu G, Thoburn KK, Rogers JD, et al. Methodological innovations in data gathering: newborn screening linkage with live births records, Michigan, 1/2007-3/ 2008. Maternal and child health journal. 2010; 14(3):360-4. Epub 2009/04/09. doi: 10.1007/s10995-009-0464-3 PMID: 19353254.
35. Lawson EH, Ko CY, Louie R, Han L, Rapp M, Zingmond DS. Linkage of a clinical surgical registry with Medicare inpatient claims data using indirect identifiers. Surgery. 2013; 153(3):423-30. Epub 2012/11/06. doi: 10.1016/j.surg.2012.08.065 PMID: 23122901.
36. Setoguchi S, Zhu Y, Jalbert JJ, Williams LA, Chen CY. Validity of deterministic record linkage using multiple indirect personal identifiers: linking a large registry to claims data. Circulation Cardiovascular quality and outcomes. 2014; 7(3):475-80. Epub 2014/04/24. doi: 10.1161/CIRCOUTCOMES.113. 000294 PMID: 24755909.